US8999957, Table 2, Compound 51

ID: ALA3654527

Chembl Id: CHEMBL3654527

PubChem CID: 56591179

Max Phase: Preclinical

Molecular Formula: C27H26FN5O3

Molecular Weight: 487.54

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  COc1cccc(F)c1CN1C[C@@H](NC(=O)c2ccc3[nH]nc(-c4ccnc(C)c4)c3c2)CCC1=O

Standard InChI:  InChI=1S/C27H26FN5O3/c1-16-12-17(10-11-29-16)26-20-13-18(6-8-23(20)31-32-26)27(35)30-19-7-9-25(34)33(14-19)15-21-22(28)4-3-5-24(21)36-2/h3-6,8,10-13,19H,7,9,14-15H2,1-2H3,(H,30,35)(H,31,32)/t19-/m0/s1

Standard InChI Key:  UJVSOLWREPSHKG-IBGZPJMESA-N

Associated Targets(non-human)

Mapk3 Mitogen-activated protein kinase 3 (111 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Mapk1 MAP kinase ERK2 (650 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 487.54Molecular Weight (Monoisotopic): 487.2020AlogP: 4.00#Rotatable Bonds: 6
Polar Surface Area: 100.21Molecular Species: NEUTRALHBA: 5HBD: 2
#RO5 Violations: HBA (Lipinski): 8HBD (Lipinski): 2#RO5 Violations (Lipinski):
CX Acidic pKa: 13.21CX Basic pKa: 4.37CX LogP: 2.56CX LogD: 2.56
Aromatic Rings: 4Heavy Atoms: 36QED Weighted: 0.43Np Likeness Score: -1.39

References

1.  (2015)  Heterocyclic compounds as ERK inhibitors, 

Source

Source(1):